Biochemical and physiological importance of the CYP26 retinoic acid hydroxylases
- PMID: 31419517
- PMCID: PMC6881548
- DOI: 10.1016/j.pharmthera.2019.107400
Biochemical and physiological importance of the CYP26 retinoic acid hydroxylases
Abstract
The Cytochrome P450 (CYP) family 26 enzymes contribute to retinoic acid (RA) metabolism and homeostasis in humans, mammals and other chordates. The three CYP26 family enzymes, CYP26A1, CYP26B1 and CYP26C1 have all been shown to metabolize all-trans-retinoic acid (atRA) it's 9-cisRA and 13-cisRA isomers and primary metabolites 4-OH-RA and 4-oxo-RA with high efficiency. While no crystal structures of CYP26 enzymes are available, the binding of various ligands has been extensively explored via homology modeling. All three CYP26 enzymes are inducible by treatment with atRA in various prenatal and postnatal tissues and cell types. However, current literature shows that in addition to regulation by atRA, CYP26 enzyme expression is also regulated by other endogenous processes and inflammatory cytokines. In humans and in animal models the expression patterns of CYP26 enzymes have been shown to be tissue and cell type specific, and the expression of the CYP26 enzymes is believed to regulate the formation of critical atRA concentration gradients in various tissue types. Yet, very little data exists on direct disease associations of altered CYP26 expression or activity. Nevertheless, data is emerging describing a variety of human genetic variations in the CYP26 enzymes that are associated with different pathologies. Interestingly, some of these genetic variants result in increased activity of the CYP26 enzymes potentially leading to complex gene-environment interactions due to variability in dietary intake of retinoids. This review highlights the current knowledge of structure-function of CYP26 enzymes and focuses on their role in human retinoid metabolism in different tissues.
Keywords: Cytochrome P450; Retinoic acid; Structure-function; Vitamin A.
Copyright © 2019 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of Interest Statement.
Nina Isoherranen holds a US Patent number: 9963439 on CYP26 Inhibitors. She has received honorariums from Pfizer and Genentech and is a consultant for Boehringer Ingleheim. Guo Zhong has no conflicts of interest to declare.
Figures
Similar articles
-
CYP26C1 Is a Hydroxylase of Multiple Active Retinoids and Interacts with Cellular Retinoic Acid Binding Proteins.Mol Pharmacol. 2018 May;93(5):489-503. doi: 10.1124/mol.117.111039. Epub 2018 Feb 23. Mol Pharmacol. 2018. PMID: 29476041 Free PMC article.
-
A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid.J Biol Chem. 2004 Jan 2;279(1):77-85. doi: 10.1074/jbc.M308337200. Epub 2003 Oct 7. J Biol Chem. 2004. PMID: 14532297
-
Comparison of the function and expression of CYP26A1 and CYP26B1, the two retinoic acid hydroxylases.Biochem Pharmacol. 2012 Jan 1;83(1):149-63. doi: 10.1016/j.bcp.2011.10.007. Epub 2011 Oct 14. Biochem Pharmacol. 2012. PMID: 22020119 Free PMC article.
-
Role of Retinoic Acid-Metabolizing Cytochrome P450s, CYP26, in Inflammation and Cancer.Adv Pharmacol. 2015;74:373-412. doi: 10.1016/bs.apha.2015.04.006. Epub 2015 May 27. Adv Pharmacol. 2015. PMID: 26233912 Free PMC article. Review.
-
Retinoic acid metabolism in cancer: potential feasibility of retinoic acid metabolism blocking therapy.Med Mol Morphol. 2023 Mar;56(1):1-10. doi: 10.1007/s00795-022-00345-6. Epub 2023 Jan 2. Med Mol Morphol. 2023. PMID: 36592231 Review.
Cited by
-
Alcohol induces neural tube defects by reducing retinoic acid signaling and promoting neural plate expansion.Front Cell Dev Biol. 2023 Dec 5;11:1282273. doi: 10.3389/fcell.2023.1282273. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38116205 Free PMC article.
-
Anti-tumor activity of all-trans retinoic acid in gastric-cancer: gene-networks and molecular mechanisms.J Exp Clin Cancer Res. 2023 Nov 11;42(1):298. doi: 10.1186/s13046-023-02869-w. J Exp Clin Cancer Res. 2023. PMID: 37951921 Free PMC article.
-
Differential DNA Methylation from Autistic Children Enriches Evidence for Genes Associated with ASD and New Candidate Genes.Brain Sci. 2023 Oct 7;13(10):1420. doi: 10.3390/brainsci13101420. Brain Sci. 2023. PMID: 37891789 Free PMC article.
-
Insights into vitamin A in bladder cancer, lack of attention to gut microbiota?Front Immunol. 2023 Aug 29;14:1252616. doi: 10.3389/fimmu.2023.1252616. eCollection 2023. Front Immunol. 2023. PMID: 37711628 Free PMC article. Review.
-
Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers.Front Cell Dev Biol. 2023 Aug 11;11:1254612. doi: 10.3389/fcell.2023.1254612. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37645246 Free PMC article. Review.
References
-
- Abu-Abed S, MacLean G, Fraulob V, Chambon P, Petkovich M, and Dolle P (2002) Differential expression of the retinoic acid-metabolizing enzymes CYP26A1 and CYP26B1 during murine organogenesis. Mech Dev 110:173–177. - PubMed
-
- Albalat R, and Cañestro C (2009) Identification of Aldh1a, Cyp26 and RAR orthologs in protostomes pushes back the retinoic acid genetic machinery in evolutionary time to the bilaterian ancestor. Chem Biol Interact 178:188–196. - PubMed
-
- Alder A, Bigler P, Werck-Reichhart D, and Al-Babili S (2009) In vitro characterization of synechocystis cyp120a1 revealed the first nonanimal retinoic acid hydroxylase. FEBS J 276:5416–5431. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
